SIRIO(SZ:300791) Jing Ji Guan Cha Wang·2025-11-09 05:43Core Insights - Xianle Health showcased its commitment to the nutrition and health sector by participating in the 8th China International Import Expo, marking its fifth appearance at this national-level exhibition [2] - The company launched the WELMAX evidence-based nutrition technology platform, aimed at addressing the trust crisis and homogenization issues in the nutrition health food industry, redefining the standards of "effectiveness" [2] - Xianle Health's General Manager emphasized the importance of the expo as a platform for global cooperation and industry innovation, highlighting the company's strategic focus on evidence-driven development [2] Industry Developments - Xianle Health announced collaborations with authoritative organizations to initiate two key standard projects: a white paper on "Scientific Evidence and Grading of Health Benefits of Foods and Ingredients" in partnership with the Chinese Nutrition Society, and a group standard for "DHA Algal Oil Nutritional Product Formulation Design and Production Processing Technology Guidelines" in collaboration with the China Standardization Research Institute and the China Nutrition Health Food Association [3] - Established in 1993, Xianle Health is a globally recognized contract R&D manufacturer in the nutrition health food sector, providing comprehensive solutions including research, product development, manufacturing, packaging, logistics, and marketing support [3] - The company went public on the Shenzhen Stock Exchange's Growth Enterprise Market in 2019, becoming the first A-share listed CDMO enterprise in the nutrition health food industry [3]